Watch & Learn — CAR-T Cells & Autoimmunity
Two key presentations from the iTOX 2026 Symposium are now available for replay, offering clinicians and researchers an in‑depth look at CAR‑T cell toxicities, spanning both hematologic complications and emerging applications in autoimmune diseases.
Camille Bigenwald, MD, PhD
CAR‑T Cells Hematotoxicity
This session provides a comprehensive overview of:
- Mechanisms underlying CAR‑T–related hematotoxicities
- Predictive factors and clinical patterns
- Management strategies informed by oncology experience
Replay link: https://gustaveroussy.ubicast.tv/permalink/v126d4af1e00a4xqc79u/iframe/
Samuel Bitoun, MD, PhD
CAR‑T Cells in Autoimmune Diseases
This presentation focuses on:
- CAR‑T cell–associated toxicities in autoimmune indications
- Acute and delayed adverse events
- Prolonged cytopenias and atypical infections
- Adapted prophylaxis strategies inspired by hematology protocols
Replay link: https://gustaveroussy.ubicast.tv/permalink/v126d4af1e00a326as9k/iframe/
These sessions provide valuable insights for specialists involved in immunotherapy, hematology, autoimmunity, and cellular therapies, highlighting evolving safety considerations and translational perspectives across disciplines.



